CA Stock MarketDetailed Quotes

INNO InnoCan Pharma Corp

Watchlist
  • 0.170
  • -0.010-5.56%
15min DelayMarket Closed Apr 4 09:30 ET
49.51MMarket Cap-12.14P/E (TTM)

InnoCan Pharma Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
115.55%29.44M
10.38%5.4M
111.22%8.62M
176.96%8.64M
333.85%6.77M
433.69%13.66M
331.10%4.89M
445.13%4.08M
652.05%3.12M
500.00%1.56M
Operating revenue
115.55%29.44M
10.38%5.4M
111.22%8.62M
176.96%8.64M
333.85%6.77M
433.69%13.66M
331.10%4.89M
445.13%4.08M
652.05%3.12M
500.00%1.56M
Cost of revenue
93.57%3.25M
64.24%992K
101.67%845K
38.92%646K
303.68%767K
271.46%1.68M
1,676.47%604K
1,132.35%419K
131.34%465K
4.40%190K
Gross profit
118.63%26.19M
2.80%4.41M
112.31%7.78M
201.13%8M
338.03%6M
468.49%11.98M
289.55%4.29M
412.45%3.66M
1,141.12%2.66M
1,656.41%1.37M
Operating expense
73.84%27.43M
2.80%5.33M
52.51%7.43M
141.46%7.47M
173.63%7.21M
88.47%15.78M
106.49%5.18M
174.37%4.87M
41.12%3.09M
38.96%2.64M
Selling and administrative expenses
85.09%25.89M
6.97%5.01M
58.82%7.05M
148.36%7.04M
234.10%6.79M
104.25%13.99M
117.32%4.68M
187.69%4.44M
63.78%2.84M
43.10%2.03M
-Selling and marketing expense
101.85%21.13M
7.49%4.09M
88.52%6.1M
168.20%5.95M
313.16%4.99M
265.54%10.47M
276.56%3.81M
350.91%3.23M
179.60%2.22M
253.22%1.21M
-General and administrative expense
35.18%4.75M
4.70%913K
-20.81%955K
76.75%1.09M
118.20%1.8M
-11.72%3.52M
-23.64%872K
46.00%1.21M
-34.36%615K
-23.56%824K
Research and development costs
-13.75%1.55M
-35.91%323K
-12.53%377K
65.37%425K
-29.80%424K
17.69%1.8M
41.18%504K
85.78%431K
-44.13%257K
26.62%604K
Operating profit
67.21%-1.25M
-2.80%-919K
129.19%352K
222.02%532K
4.27%-1.21M
39.31%-3.8M
36.55%-894K
-13.77%-1.21M
77.95%-436K
30.40%-1.27M
Net non-operating interest income (expenses)
-130.43%-7K
-120.00%-3K
33.33%-2K
50.00%3K
-155.56%-5K
21.05%23K
150.00%15K
-142.86%-3K
-81.82%2K
280.00%9K
Non-operating interest income
--0
--0
--0
0.00%3K
--0
9.52%23K
62.50%13K
--0
-72.73%3K
--10K
Non-operating interest expense
--7K
250.00%3K
-33.33%2K
----
400.00%5K
--0
-200.00%-2K
--3K
--1K
-80.00%1K
Other net income (expenses)
955.51%2.17M
211.45%925K
156.96%352K
2,265.79%899K
-110.34%-3K
-110.77%-254K
26.92%297K
-169.36%-618K
-72.66%38K
-97.35%29K
Gain on sale of security
955.51%2.17M
211.45%925K
156.96%352K
2,265.79%899K
-110.34%-3K
-110.77%-254K
26.92%297K
-169.36%-618K
-72.66%38K
-97.35%29K
Income before tax
122.78%919K
100.52%3K
138.42%702K
462.12%1.43M
0.65%-1.22M
-3.76%-4.03M
50.21%-582K
-1,027.78%-1.83M
78.33%-396K
-68.45%-1.23M
Income tax
451.87%1.18M
-76.17%51K
418K
478K
234K
21,300.00%214K
21,300.00%214K
0
0
0
Earnings from equity interest net of tax
Net income
93.83%-262K
93.97%-48K
115.54%284K
341.41%956K
-18.40%-1.45M
-9.23%-4.25M
31.97%-796K
-1,027.78%-1.83M
78.33%-396K
-68.45%-1.23M
Net income continuous operations
93.83%-262K
93.97%-48K
115.54%284K
341.41%956K
-18.40%-1.45M
-9.23%-4.25M
31.97%-796K
-1,027.78%-1.83M
78.33%-396K
-68.45%-1.23M
Noncontrolling interests
247.79%1.57M
-24.14%66K
187.00%574K
399.19%619K
645.24%313K
461.60%452K
135.14%87K
3,233.33%200K
236.26%124K
153.85%42K
Net income attributable to the company
60.98%-1.83M
87.09%-114K
85.69%-290K
164.81%337K
-39.13%-1.77M
-24.87%-4.7M
26.84%-883K
-1,106.55%-2.03M
70.05%-520K
-95.08%-1.27M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
60.98%-1.83M
87.09%-114K
85.69%-290K
164.81%337K
-39.13%-1.77M
-24.87%-4.7M
26.84%-883K
-1,106.55%-2.03M
70.05%-520K
-95.08%-1.27M
Diluted earnings per share
50.00%-0.01
33.33%-0.004
85.71%-0.001
150.00%0.001
0.00%-0.005
-25.00%-0.02
-20.00%-0.006
-600.00%-0.007
71.43%-0.002
-66.67%-0.005
Basic earnings per share
50.00%-0.01
33.33%-0.004
85.71%-0.001
150.00%0.001
0.00%-0.005
-25.00%-0.02
-20.00%-0.006
-600.00%-0.007
71.43%-0.002
-66.67%-0.005
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 115.55%29.44M10.38%5.4M111.22%8.62M176.96%8.64M333.85%6.77M433.69%13.66M331.10%4.89M445.13%4.08M652.05%3.12M500.00%1.56M
Operating revenue 115.55%29.44M10.38%5.4M111.22%8.62M176.96%8.64M333.85%6.77M433.69%13.66M331.10%4.89M445.13%4.08M652.05%3.12M500.00%1.56M
Cost of revenue 93.57%3.25M64.24%992K101.67%845K38.92%646K303.68%767K271.46%1.68M1,676.47%604K1,132.35%419K131.34%465K4.40%190K
Gross profit 118.63%26.19M2.80%4.41M112.31%7.78M201.13%8M338.03%6M468.49%11.98M289.55%4.29M412.45%3.66M1,141.12%2.66M1,656.41%1.37M
Operating expense 73.84%27.43M2.80%5.33M52.51%7.43M141.46%7.47M173.63%7.21M88.47%15.78M106.49%5.18M174.37%4.87M41.12%3.09M38.96%2.64M
Selling and administrative expenses 85.09%25.89M6.97%5.01M58.82%7.05M148.36%7.04M234.10%6.79M104.25%13.99M117.32%4.68M187.69%4.44M63.78%2.84M43.10%2.03M
-Selling and marketing expense 101.85%21.13M7.49%4.09M88.52%6.1M168.20%5.95M313.16%4.99M265.54%10.47M276.56%3.81M350.91%3.23M179.60%2.22M253.22%1.21M
-General and administrative expense 35.18%4.75M4.70%913K-20.81%955K76.75%1.09M118.20%1.8M-11.72%3.52M-23.64%872K46.00%1.21M-34.36%615K-23.56%824K
Research and development costs -13.75%1.55M-35.91%323K-12.53%377K65.37%425K-29.80%424K17.69%1.8M41.18%504K85.78%431K-44.13%257K26.62%604K
Operating profit 67.21%-1.25M-2.80%-919K129.19%352K222.02%532K4.27%-1.21M39.31%-3.8M36.55%-894K-13.77%-1.21M77.95%-436K30.40%-1.27M
Net non-operating interest income (expenses) -130.43%-7K-120.00%-3K33.33%-2K50.00%3K-155.56%-5K21.05%23K150.00%15K-142.86%-3K-81.82%2K280.00%9K
Non-operating interest income --0--0--00.00%3K--09.52%23K62.50%13K--0-72.73%3K--10K
Non-operating interest expense --7K250.00%3K-33.33%2K----400.00%5K--0-200.00%-2K--3K--1K-80.00%1K
Other net income (expenses) 955.51%2.17M211.45%925K156.96%352K2,265.79%899K-110.34%-3K-110.77%-254K26.92%297K-169.36%-618K-72.66%38K-97.35%29K
Gain on sale of security 955.51%2.17M211.45%925K156.96%352K2,265.79%899K-110.34%-3K-110.77%-254K26.92%297K-169.36%-618K-72.66%38K-97.35%29K
Income before tax 122.78%919K100.52%3K138.42%702K462.12%1.43M0.65%-1.22M-3.76%-4.03M50.21%-582K-1,027.78%-1.83M78.33%-396K-68.45%-1.23M
Income tax 451.87%1.18M-76.17%51K418K478K234K21,300.00%214K21,300.00%214K000
Earnings from equity interest net of tax
Net income 93.83%-262K93.97%-48K115.54%284K341.41%956K-18.40%-1.45M-9.23%-4.25M31.97%-796K-1,027.78%-1.83M78.33%-396K-68.45%-1.23M
Net income continuous operations 93.83%-262K93.97%-48K115.54%284K341.41%956K-18.40%-1.45M-9.23%-4.25M31.97%-796K-1,027.78%-1.83M78.33%-396K-68.45%-1.23M
Noncontrolling interests 247.79%1.57M-24.14%66K187.00%574K399.19%619K645.24%313K461.60%452K135.14%87K3,233.33%200K236.26%124K153.85%42K
Net income attributable to the company 60.98%-1.83M87.09%-114K85.69%-290K164.81%337K-39.13%-1.77M-24.87%-4.7M26.84%-883K-1,106.55%-2.03M70.05%-520K-95.08%-1.27M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 60.98%-1.83M87.09%-114K85.69%-290K164.81%337K-39.13%-1.77M-24.87%-4.7M26.84%-883K-1,106.55%-2.03M70.05%-520K-95.08%-1.27M
Diluted earnings per share 50.00%-0.0133.33%-0.00485.71%-0.001150.00%0.0010.00%-0.005-25.00%-0.02-20.00%-0.006-600.00%-0.00771.43%-0.002-66.67%-0.005
Basic earnings per share 50.00%-0.0133.33%-0.00485.71%-0.001150.00%0.0010.00%-0.005-25.00%-0.02-20.00%-0.006-600.00%-0.00771.43%-0.002-66.67%-0.005
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.

Unlock Now
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.

Unlock Now